Mirum (MIRM) Director Sells $397,700 in Company Stock

Saira Ramasastry, a director at Mirum Pharmaceuticals (MIRM), sold $397,700 worth of company stock. The transaction may indicate changes in insider sentiment regarding the company's future. Insider selling can influence market perception and investor confidence. Such sales could lead to fluctuations in MIRM's stock price, depending on investor reaction to these insider movements.